AMSF
AMERISAFE, Inc.
AMSF offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BAC
Bank of America Corporation
BAC has the edge over AMSF overall, supported by stronger fundamentals and stronger modeled upside.
AMSF Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
AMSF's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like AMSF.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
AMSF PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 9x | $19.32 | — |
| Forward | 10x | $19.32 | — |
| Cheap | 12x | $26.07 | +35% |
| Fair | 15x | $31.51 | +63% |
| Expensive | 18x | $38.29 | +98% |
Historical ranges are pointers, not guarantees.
AMSF has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
AMSF Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect AMSF's earnings and profitability to decline, with its revenue holding steady.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over AMSF on the outlook, with more favorable valuation and earnings expectations.
AMSF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.87 | -13% |
| Q3 2026 | $2.15 | -18% |
| Q2 2026 | $2.48 | -6.1% |
| Q1 2026 | $2.43 | -2% |
| Q4 2025 | $2.47 | -15% |
| Q3 2025 | $2.61 | -18% |
| Q2 2025 | $2.64 | -11% |
| Q1 2025 | $2.48 | -23% |
| Q4 2024 | $2.89 | -11% |
AMSF's earnings per share have fallen from their peak: $2.15 over the past year, against $4.91 in early 2021.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over AMSF on earnings, with more consistent year-over-year improvement.
AMSF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $79.8M | -2.6% |
| Q2 2026 | $92M | +13% |
| Q1 2026 | $80.1M | +10% |
| Q4 2025 | $81.6M | +10% |
| Q3 2025 | $82M | +4.2% |
| Q2 2025 | $81.1M | +6.9% |
| Q1 2025 | $72.6M | -9.8% |
| Q4 2024 | $74M | -7.6% |
AMSF's revenue has picked up after four years of holding roughly level: $80M last quarter, down 2.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -10 points |
| Q2 2026 | 20% | -1.7 points |
| Q1 2026 | 13% | -2.8 points |
| Q4 2025 | 16% | -7.1 points |
| Q3 2025 | 21% | -1.3 points |
| Q2 2025 | 22% | +3.4 points |
| Q1 2025 | 15% | -10 points |
| Q4 2024 | 23% | -7.2 points |
AMSF's operating margin was 11% last quarter, down 10 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over AMSF on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over AMSF on profitability, with a higher operating margin.
AMSF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.8M | -71% |
| Q2 2026 | $1.8M | +$11.3M |
| Q1 2026 | -$2.7M | -$930K |
| Q4 2025 | $10.5M | -3.4% |
| Q3 2025 | $9.8M | +16% |
| Q2 2025 | -$9.5M | -$6.9M |
| Q1 2025 | -$1.8M | -127% |
| Q4 2024 | $10.8M | +174% |
AMSF's free cash flow was $12M over the past year, up 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like AMSF.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over AMSF on cash flow, with more consistent year-over-year improvement.
AMSF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -62.3K shares |
| 1 year | -2.3% | -432K shares |
| 3 years | -3% | -584K shares |
| 5 years | -4% | -768K shares |
| Available history | -3.6% | -689K shares |
AMSF has 19M diluted shares, down 2.3% from a year ago.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over AMSF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
AMSF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
AMSF has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
AMSF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.6 | Oversold |
| Stochastic | 1.7 | Oversold |
AMSF's weekly RSI is 25 (oversold) and its Stochastic is 2 (oversold).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
AMSF PE vs Financial Services Sector
| Metric | AMSF | Sector median | Relative |
|---|---|---|---|
| PE | 9x | 13x | 31% below |
| PE % | 0 | 63 | 63 pts below |
AMSF has the edge over BAC on valuation relative to its sector.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
AMSF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $22.9 | 15% below |
| 20 week MA | $26.5 | 27% below |
| 50 week MA | $31.3 | 38% below |
| 100 week MA | $38.9 | 50% below |
| 200 week MA | $44.7 | 57% below |
AMSF is in a downtrend: it's below all five of its weekly moving averages, and 57% below its 200-week average.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over AMSF on trend strength, trading above more of its moving averages.
AMSF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $65.7 | $57.2 | -13% |
| 2021 | $57.2 | $51.6 | -9.8% |
| 2022 | $51.6 | $53.3 | +3.3% |
| 2023 | $53.3 | $46.8 | -12% |
| 2024 | $46.8 | $51.6 | +10% |
| 2025 | $51.6 | $38.5 | -25% |
| 2026 YTD | $38.5 | $19.3 | -50% |
AMSF has finished lower in four of the last six years. It's down 50% so far in 2026.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over AMSF on returns for 2026, with the stronger performance.